Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Seksik

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Gastroenterologie Clinique Et Biologique|October 5, 2010
[Gut microbiota and IBD]P Seksik
Gastroenterologie Clinique Et Biologique|September 1, 2009
[Inflammatory bowel disease: from sulfasalazine to biologics]J Cosnes, P Seksik
The British Journal of Nutrition|September 7, 2002
Probiotics and intestinal health effects: a clinical perspectiveP Marteau, P Seksik, R Jian
Endoscopy|February 7, 2004
Inflammatory bowel disease: what is new?P Marteau, F Daniel, P Seksik, et al.
Gastroenterologie Clinique Et Biologique|February 2, 2010
Bacteriotherapy for inflammatory bowel disease: therapeutic tool and/or pharmacological vectors?P Marteau, H Sokol, X Dray, et al.
Journal of Clinical Microbiology|September 7, 2006
Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitisH Sokol, P Lepage, P Seksik, et al.
Intensive Care Medicine|May 26, 1999
Fatal herpetic hepatitis in adult following short corticotherapy: a case reportP Seksik, J Gozlan, C Guitton, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2016
The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel diseaseF Carrat, P Seksik, J-F Colombel, et al.
Alimentary Pharmacology & Therapeutics|February 19, 2009
Incidence of benign upper respiratory tract infections, HSV and HPV cutaneous infections in inflammatory bowel disease patients treated with azathioprineP Seksik, J Cosnes, H Sokol, et al.
Alimentary Pharmacology & Therapeutics|September 9, 2004
Review article: gut flora and inflammatory bowel diseaseP Marteau, P Lepage, I Mangin, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Gastroenterologie Clinique Et Biologique|October 5, 2010
[Gut microbiota and IBD]P Seksik
Gastroenterologie Clinique Et Biologique|September 1, 2009
[Inflammatory bowel disease: from sulfasalazine to biologics]J Cosnes, P Seksik
The British Journal of Nutrition|September 7, 2002
Probiotics and intestinal health effects: a clinical perspectiveP Marteau, P Seksik, R Jian
Endoscopy|February 7, 2004
Inflammatory bowel disease: what is new?P Marteau, F Daniel, P Seksik, et al.
Gastroenterologie Clinique Et Biologique|February 2, 2010
Bacteriotherapy for inflammatory bowel disease: therapeutic tool and/or pharmacological vectors?P Marteau, H Sokol, X Dray, et al.
Journal of Clinical Microbiology|September 7, 2006
Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitisH Sokol, P Lepage, P Seksik, et al.
Intensive Care Medicine|May 26, 1999
Fatal herpetic hepatitis in adult following short corticotherapy: a case reportP Seksik, J Gozlan, C Guitton, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2016
The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel diseaseF Carrat, P Seksik, J-F Colombel, et al.
Alimentary Pharmacology & Therapeutics|February 19, 2009
Incidence of benign upper respiratory tract infections, HSV and HPV cutaneous infections in inflammatory bowel disease patients treated with azathioprineP Seksik, J Cosnes, H Sokol, et al.
Alimentary Pharmacology & Therapeutics|September 9, 2004
Review article: gut flora and inflammatory bowel diseaseP Marteau, P Lepage, I Mangin, et al.
Pageof 4